Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Clinical Trial of Intravenous Paclitaxel Plus Intraperitoneal Cisplatin for Neo-adjuvant Chemotherapy in Patients With Advanced Ovarian Cancer

NCT04885270 is registered in ClinicalTrials.gov with West China Second University Hospital as lead sponsor.

NCT NCT04885270
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04885270 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Clinical Trial of Intravenous Paclitaxel Plus Intraperitoneal Cisplatin for Neo-adjuvant Chemotherapy in Patients With Advanced Ovarian Cancer
Lead sponsor
West China Second University Hospital
Phase
Phase 3
Overall status
Unknown status
Start date
August 4, 2021
Completion date
March 31, 2024
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

epithelial carcinoma, ovarian, neoadjuvant chemotherapy